ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
95,409.77
-1.85%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Cannara Biotech Inc (LOVE) Quote

Cannara Biotech Inc

Cannara Biotech Inc (LOVE)

Cannara Biotech Inc
Lovesac Company
0.75
-0.05
(-6.25%)
Closed December 22 4:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.75
Bid
0.75
Ask
0.79
Volume
126,428
0.75 Day's Range 0.81
0.00 52 Week Range 0.00
Market Cap
67.729M
Previous Close
0.80
Open
0.80
Last Trade
500
@
0.75
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
90,305,000
Dividend Yield
-
PE Ratio
9.75
Earnings Per Share (EPS)
0.08
Revenue
57.56M
Net Profit
6.95M

About Cannara Biotech Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cannara.ca
Headquarters
Saint-laurent, Quebec, Can
Founded
-
Cannara Biotech Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker LOVE. The last closing price for Cannara Biotech was $0.80. Over the last year, Cannara Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Cannara Biotech currently has 90,305,000 shares outstanding. The market capitalization of Cannara Biotech is $72.24 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 9.75.

Ask ADVFN Intelligence (AI)

LOVE Latest News

More News

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

December 16 2024
GlobeNewswire Inc.

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

December 12 2024
GlobeNewswire Inc.

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total...

November 25 2024
GlobeNewswire Inc.

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...

August 16 2024
GlobeNewswire Inc.

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...

July 23 2024
GlobeNewswire Inc.

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024

Cannara Biotech publie ses résultats financiers pour le deuxième trimestre de 2024 Canada NewsWire MONTRÉAL, le 29 avril 2024 Les revenus nets ont augmenté pour atteindre 19,7...

April 29 2024
PR Newswire (Canada)

Cannara Biotech annonce des résultats records pour le premier trimestre de 2024 : Croissance robuste continue et expansion du marché

Cannara Biotech annonce des résultats records pour le premier trimestre de 2024 : Croissance robuste continue et expansion du marché Canada NewsWire MONTRÉAL, le 30 janv. 2024 Des...

January 30 2024
PR Newswire (Canada)

Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services de teneur de marché

Cannara Biotech annonce l'engagement d'Independent Trading Group (ITG) pour la prestation de services de teneur de marché Canada NewsWire MONTRÉAL, le 8 janv. 2024 MONTRÉAL, le...

January 08 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

LOVE - Frequently Asked Questions (FAQ)

What is the current Cannara Biotech share price?
The current share price of Cannara Biotech is $ 0.75
How many Cannara Biotech shares are in issue?
Cannara Biotech has 90,305,000 shares in issue
What is the market cap of Cannara Biotech?
The market capitalisation of Cannara Biotech is CAD 72.24M
What is the 1 year trading range for Cannara Biotech share price?
Cannara Biotech has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Cannara Biotech?
The price to earnings ratio of Cannara Biotech is 9.75
What is the cash to sales ratio of Cannara Biotech?
The cash to sales ratio of Cannara Biotech is 1.18
What is the reporting currency for Cannara Biotech?
Cannara Biotech reports financial results in CAD
What is the latest annual turnover for Cannara Biotech?
The latest annual turnover of Cannara Biotech is CAD 57.56M
What is the latest annual profit for Cannara Biotech?
The latest annual profit of Cannara Biotech is CAD 6.95M
What is the registered address of Cannara Biotech?
The registered address for Cannara Biotech is 333 D��CARIE, SUITE 200, SAINT-LAURENT, QUEBEC, H4N 3M9
What is the Cannara Biotech website address?
The website address for Cannara Biotech is www.cannara.ca
Which industry sector does Cannara Biotech operate in?
Cannara Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GNFIGenifi Inc
$ 0.015
(200.00%)
4k
GHR.HGolden Harp Resources Inc
$ 0.10
(185.71%)
2.73k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
2k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
1.1k
GAR.HGreen Arrow Resources Inc
$ 0.045
(80.00%)
1,000
CBAChampion Bear Resources Ltd
$ 0.015
(-62.50%)
101k
NIKL.HGK Resources LTD
$ 0.045
(-50.00%)
1,000
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
106.09k
COOOstrom Climate Solutions Inc
$ 0.05
(-50.00%)
109.5k
QNCQuantum Emotion Corp
$ 0.435
(26.09%)
7.32M
GXUGoviEx Uranium Inc
$ 0.055
(10.00%)
4.68M
FUUF3 Uranium Corp
$ 0.25
(6.38%)
3.64M
AUUAALUULA Composites Inc
$ 0.05
(0.00%)
3.63M
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M

Discussion

View Full Feed
learningcurve2020 learningcurve2020 3 minutes ago
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: "Open Sans", sans-serif, "Segoe UI"; background-color: rgba(255, 255, 255, 1)">>The company says its TriMix technology acts as an adjuvant to activate dendritic cells to induce strong T-cell responses to the antigens.
NWBO
TMaga TMaga 3 minutes ago
Market Cap: Micro Cap
$7.69M
Shares Outstanding
9.82M
Shares held by Institutions
16.46%
Enterprise Value
$17.49M
HCWC
MightyX MightyX 3 minutes ago
By controlling shareprice..the trader-group-fraud forces company to dilute..at undervalued-marketcaps.
TPTW
JTORENCE JTORENCE 4 minutes ago
XMaster2023 " The true longs are waiting until the second combo trial is announced with another BP, at the earliest."
You are dreaming. A high percentage of true longs (5 years or more) will head for the exits upon a UK approval. imo
NWBO
MightyX MightyX 4 minutes ago
These illegit-individuals work-with-eachother forming groups to control shareprice.
TPTW
LTR LTR 5 minutes ago
Make sure you stick to it this time. I work with a guy like you. He's always leaving work for a new job. He's been doing that now for 10 years. You lose respect that way.
NWBO
DiscoverGold DiscoverGold 5 minutes ago
NY Gold Futures »» Weekly Summary Analysis
By: Marty Armstrong | November 21, 2024

NY Gold Futures closed today at 26451 and is trading up about 27% for the year from last year's settlement of 20718. At the moment, this market is currently trading below last month's close
GDX
MightyX MightyX 6 minutes ago
Illegit individuals buy controlling-stake of tradeable-OS in-pursuit-of hostile takeovers.
TPTW
TrendTrade2016 TrendTrade2016 6 minutes ago
LEADING INDICATORS CLEARLY SHOWED ALGO WASH FRIDAY
GVSI
al44 al44 6 minutes ago
Capitalism and enlightened self-interest

By Jay Davidson


Central planning (socialism) always fails at the economic level. No government bureaucrat (central planner) can sustain an economy that forces an individual. The socialist knows this, so he uses guilt (c
blackhawks blackhawks 7 minutes ago
They're not my hopes but rather predictable results from ill-thought out policies by belief centric nitwits.

Any notion that Canada and NATO are not already 'rearmed' is belied by the facts. And why would Pooty's lapdog try to hurt his master?

There is no 'war on fossi
MightyX MightyX 7 minutes ago
Precisely-why CEO’s in vulnerable positions(company/industry-leaders)own controlling-stake of their companies.
TPTW
delerious1 delerious1 7 minutes ago
lf you do a search on "Long" on stocks you will see that it is defined as the opposite of "short"....so in that context anyone who buys a stock is considered long....anyone who sells a stock that they don't yet own is short...black and white.....that is where the confusion lies....I buy stocks, neve
NBRI
Hoskuld Hoskuld 8 minutes ago
I disagree that the ADL endpoint is a big deal - it is now pretty discredited as a critically important measure. US trial sites also no big deal - the trial was vetted with and approved bythe FDA, and all sites were in countries that are less corrupt than the USA - and the patient populations were
AVXL
learningcurve2020 learningcurve2020 8 minutes ago
AI Sky not going to address my questions, I can see.  Yes, I was the first to introduce many ideas here but the disciples always twisted all of it giving "Managment" a free pass to destroy value.  I was the first here to bring up Rosewell's SurVaxM too.  Now everyone has their hand in DC's so Advent
NWBO
TrendTrade2016 TrendTrade2016 8 minutes ago
NO MOVE COMING HERE ANYTIME SOON...WEEKLY HAS BIG ISSUES ON JAN 27TH, SO IF THE STOCK DOES NOT MOVE UP BY THE 20TH ITS TOAST UNTIL JUNE
GVSI
1vman 1vman 8 minutes ago
****🚽HYMC🚽 ( Hyturd ) So much for the "Gold standard " nonsense - this company has not mined gold period - Wh👀ps

A little DD goes a long way

ENOUGH SAID HUZZAH 🤪
HYMC
Jackxkr Jackxkr 9 minutes ago
Never shorted anything in my life . You have to cut your losses at some point. I am hoping the mtd gets dismissed next week, we get a bump into mid 30s and i sell at a 50 % loss. I think next year silver booms. Back to familiar grounds for me.
NWBO
BRoberts1982 BRoberts1982 9 minutes ago
Correction:

The Green Bond is almost a year old, launched January 23, 2024 ... and nobody wanted it.
That's almost a year old and almost nobody wanted it.
CLNV
Elroy Jetson Elroy Jetson 12 minutes ago
Are any Americans sick of winning yet?

https://scontent-ord5-1.xx.fbcdn.net/v/t39.30808-6/471106944_1126706832790857_2039492883262940533_n.jpg?stp=dst-jpg_s600x600_tt6&_nc_cat=101&ccb=1-7&_nc_sid=127cfc&_nc_ohc=aRyEHNB8zJwQ7kNvgGzQouL&_nc_zt=23&_nc_ht=scontent-ord5-1.xx&_nc_gid=Awrh4k
1vman 1vman 12 minutes ago
*****🚽SHMP🚽 JUMBO SHORTS have made a killing here -- .00001's coming ( Expert market )

ENOUGH SAID HUZZAH🤪 !!!
SHMP
XMaster2023 XMaster2023 12 minutes ago
Jack and Guzzi are both shorts and paid bashers in case you’re new to this board. The longs are not selling after the stock price hits .30. The true longs are waiting until the second combo trial is announced with another BP, at the earliest. Up list hopefully before that but no telling.
NWBO
BIOCHEMUP BIOCHEMUP 13 minutes ago
Price target
KULR

Your Recent History

TSXV
LOVE
Cannara Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads